On the other hand, our previous study demonstrated that circadian variation in PD‐1 positive tumor‐associated macrophages (TAMs), which are highly expressed during the active phase, contributes to time‐dependent changes in the efficacy of ICIs.18 The gene discussed is PDCD1; the disease is neoplasm.